CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages

Table 1

Patient characteristics.

	Benign ()	BOT I+II ()	EOC I+II ()
Age (year)	32.0 (27.0-40.0)	32.0 (27.0-41.0)	48.0 (41.0-58.75)^^
Premenopausal	218	122	61
Postmenopausal	20	22	47
FIGO stages
I	—	140	76
II	—	4	32
Histopathology
Serous	—	91	43
Mucinous	—	40	10
Endometrioid	—	9	23
Clear cell	—	4	32

Note: data of age are presented as the median (interquartile range). Abbreviations:  = number; FIGO = International Federation of Gynecology and Obstetrics; BOT I+II = borderline ovarian tumors in FIGO stages I and II; EOC I+II = epithelial ovarian cancer in FIGO stages I and II.